Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
≥156-Week Apremilast Safety in Psoriasis and Psoriatic Arthritis Patients: Pooled Analysis of the ESTEEM and PALACE Phase 3 Trials. 92nd National Congress of the Italian Society of Dermatology Medical, Surgical, Beauty, and Sexually Transmitted Diseases (SIDeMaST), Sorrento, Italy, May 2017
92nd National Congress of the Italian Society of Dermatology Medical, Surgical, Beauty, and Sexually Transmitted Diseases (SIDeMaST) (2017)
  • J Crowley
  • J Wollenhaupt
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Disciplines
Publication Date
May, 2017
Citation Information
J Crowley, J Wollenhaupt, Philip Mease and et.al.. "≥156-Week Apremilast Safety in Psoriasis and Psoriatic Arthritis Patients: Pooled Analysis of the ESTEEM and PALACE Phase 3 Trials. 92nd National Congress of the Italian Society of Dermatology Medical, Surgical, Beauty, and Sexually Transmitted Diseases (SIDeMaST), Sorrento, Italy, May 2017" 92nd National Congress of the Italian Society of Dermatology Medical, Surgical, Beauty, and Sexually Transmitted Diseases (SIDeMaST) (2017)
Available at: http://works.bepress.com/philip-mease/275/